Christopher Aulin

Located in Stockholm, Sweden.

Christopher is now part of the great team that is taking the amazing product Capitainer qDBS to the market with the goal to and establish it as the new gold standard for blood collection outside of health care facilities.


Christopher has 20 years of sales and management positions within IT and health care. Over the last ten years, Christopher has gone from being CEO of a rapidly growing company that conducted a successful exit by sale to Alere, to being part of the executive team including being General Manager of Denmark at Alere. After the merger between Abbott and Alere, Christopher was promoted to Nordic Director of the Toxicology business unit including GM for all TOX companies within Abbott Nordic organization. Christopher went straight from Abbott to Capitainer after realizing the potential of the Container technology.

“Nothing bad happens that doesn’t have something good in it”.